...
首页> 外文期刊>Journal of cardiovascular magnetic resonance : >Preservation of cardiac function and energy reserve by the angiotensin-converting enzyme inhibitor quinapril during postmyocardial infarction remodeling in the rat.
【24h】

Preservation of cardiac function and energy reserve by the angiotensin-converting enzyme inhibitor quinapril during postmyocardial infarction remodeling in the rat.

机译:在大鼠心肌梗死重塑期间,血管紧张素转化酶抑制剂奎那普利可保持心脏功能和能量储备。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Angiotensin-converting enzyme (ACE) inhibitors show beneficial long-term hemodynamic effects in chronically infarcted hearts. The purpose of this study was to test whether prevention of the deterioration of mechanical function by ACE inhibitors is related to beneficial effects on high-energy phosphate metabolism that is deranged in heart failure. METHODS: Twelve-week old rats were randomly assigned to ligation of the left coronary artery [mycardial infarction (MI)] or sham operation (Sham) and to the ACE inhibitor quinapril (+Q) (6 mg/kg/day per gavage) or placebo treatment. Eight weeks later, cardiac function was measured in the isolated heart by a left ventricular balloon (pressure-volume curves), and energy metabolism of residual intact myocardium was analyzed in terms of total and isoenzyme creatine kinase activity (spectrophotometry), steady-state levels [adenosine triptosphate (ATP), phosphocreatine], and turnover rates (creatine kinase reaction velocity) of high-energy phosphates [31P nuclear magnetic resonance (NMR)] and total creatine content [high-performance liquid chromatography (HPLC)]. RESULTS: Quinapril prevented post-MI hypertrophy and partially prevented left ventricular contractile dysfunction [maximum left ventricular developed pressure 166+/-6, 83+/-16 (p < 0.05 MI vs. Sham), 139+/-13 mm Hg (p < 0.05 quinapril treated vs. untreated) in Sham, MI and MI+Q hearts]. Residual intact failing myocardium showed a 17% decrease of MM-CK and a 16% decrease of mito-CK activity. Total creatine was reduced by 23%, phosphocreatine by 26% and CK reaction velocity by 30%. Parallel to improved function, treatment with quinapril largely prevented the impairment of energy metabolism occuring post-MI. CONCLUSIONS: quinapril treatment results in an improvement of high-energy phosphate metabolism, of energy reserve via the creatine kinase reaction, and of contractile performance post-MI.
机译:目的:血管紧张素转换酶(ACE)抑制剂在慢性梗死心脏中显示出有益的长期血流动力学作用。这项研究的目的是检验ACE抑制剂预防机械功能恶化是否与对高能磷酸盐代谢的有益作用有关,后者在心力衰竭中是失调的。方法:将十二周大的大鼠随机分为左冠状动脉[心肌梗塞(MI)]或假手术(Sham)和ACE抑制剂奎纳普利(+ Q)结扎(每管每天6 mg / kg /天)或安慰剂治疗。八周后,通过左心室球囊测量离体心脏的心脏功能(压力-容量曲线),并根据总和同工酶肌酸激酶活性(分光光度法),稳态水平分析残留完整心肌的能量代谢[高能磷酸盐[31P核磁共振(NMR)]和总肌酸含量[高效液相色谱(HPLC)]的[三磷酸腺苷(ATP),磷酸肌酸]和周转率(肌酸激酶反应速度)。结果:奎那普利预防了心肌梗死后肥大,部分预防了左心室收缩功能障碍[最大左心室发育压力166 +/- 6、83 +/- 16(相对于假手术,p <0.05 MI),139 +/- 13 mm Hg(在假手术,MI和MI + Q心脏中,p <0.05喹那普利治疗组与未治疗组的比较]。残留的完整衰竭心肌显示MM-CK活性降低了17%,而mito-CK活性降低了16%。总肌酸降低了23%,磷酸肌酸降低了26%,CK反应速度降低了30%。与改善功能同时,奎纳普利治疗在很大程度上预防了心梗后发生的能量代谢障碍。结论:喹那普利治疗可改善高能磷酸盐代谢,通过肌酸激酶反应的能量储备以及心肌梗死后的收缩性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号